Document is current

Article History

Received: 17 July 2018

Accepted: 6 March 2019

First Online: 29 April 2019

Ethics approval and consent to participate

: Not applicable.

: Approved by all authors, the corresponding author assumes responsibility.

: Adriana Maria Kakehasi Research funds: CNPq, SBR, FAPEMIG Support for Scientific Events: Abbvie, BMS, Janssen Lecture Fees: UCB, Janssen, Pfizer, Roche, BMS Clinical research: Roche, Pfizer Advisory board: Janssen, Roche, BMS, Pfizer.Alexandre Wagner S de Souza has received financial support as an advisory board member for Roche. Financial competing interest: none.Caroline Araújo Magnata da Fonte: none.Clayton Brenol Has received personal or institutional support from Abbvie, Bristol, Janssen, Pfizer and Roche; has delivered speeches at events related to this work and sponsored by Abbvie, Pfizer and Roche. Financial competing interest: none.Claudia Marques: Non-financial and financial competing interests related to this publicationCyrla Zaltman: Non-financial and financial competing interests related to this publicationEduardo Ferreira Borba was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq #307226/2014-0). Financial competing interest: none.Gecilmara Salviato Pileggi has received fees for lectures and talks at events related to this study sponsored by Abbvie, Janssen, and UCB. The authors declare no financial competing interest.Georges Basile Christopoulos: noneIeda M M Laurindo – has no competing interests related to this work. Financial competing interests: none.Isabella Ballalai: has received funding for meetings related to this work sponsored by the Brazilian Ministry of Health (CTAI-PNI), fees for lectures and advisory board sponsored by Sanofi Pasteur, Pfizer and MSD.Izaias Pereira da Costa Non-financial competing interestsLessandra Michelin has received funding for meetings related to this work sponsored by the Brazilian Ministry of Health (CTAI-PNI). Financial competing interest: none.Licia Maria Henrique da Mota Has received personal or institutional support from Abbvie, Janssen, Pfizer and Roche; has delivered speeches at events related to this work and sponsored by Abbvie, Janssen, Pfizer, Roche and UCB. Financial competing interest: none.Lilian David de Azevêdo Valadares has received for lectures fees and speeches at events related to this work sponsored by Janssen and Novartis. Financial competing interest: none.Liliana Andrade Chebli has received for lecture fees and speeches at events not related to this work sponsored by Takeda. Financial competing interest: none.Marcos Renato de Assis has received personal or institutional support from Apsen and Lilly; has given lectures and/or consultancy to Novartis, UCB and Janssen not related to this work. Financial competing interest: none.Marcus Vinícius Guimarães de Lacerda has no conflict of interest.Michel Alexandre Yazbek has no competing interests related to this work. Financial competing interests: none.Rejane Maria Rodrigues de Abreu Vieira has no conflicts of interest.Renato Kfouri has received fees for lectures and advisory board sponsored by Sanofi Pasteur.Rosana Richtmann has received for lectures fees sponsored by Abbvie, Pfizer and MSD. Financial competing interest: none.Selma Merenlender is presently supported by SRRJ.Valéria Valim has no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.